• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Can Identifying Pulmonary Exacerbation Phenotypes Guide New Treatment Approaches for Cystic Fibrosis?

作者信息

Caverly Lindsay J

机构信息

Division of Pediatric Pulmonology, University of Michigan Medical School, Ann Arbor, Michigan.

出版信息

Ann Am Thorac Soc. 2022 Nov;19(11):1799-1801. doi: 10.1513/AnnalsATS.202208-703ED.

DOI:10.1513/AnnalsATS.202208-703ED
PMID:36318079
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9667808/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2b1/9667808/fe62df3acd24/AnnalsATS.202208-703EDUf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2b1/9667808/fe62df3acd24/AnnalsATS.202208-703EDUf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2b1/9667808/fe62df3acd24/AnnalsATS.202208-703EDUf1.jpg

相似文献

1
Can Identifying Pulmonary Exacerbation Phenotypes Guide New Treatment Approaches for Cystic Fibrosis?识别肺部加重期表型能否指导囊性纤维化的新治疗方法？
Ann Am Thorac Soc. 2022 Nov;19(11):1799-1801. doi: 10.1513/AnnalsATS.202208-703ED.
2
Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial.家用电子症状和肺功能监测以检测囊性纤维化肺部恶化的随机试验的原理和设计：囊性纤维化恶化早期干预（eICE）试验。
Contemp Clin Trials. 2013 Nov;36(2):460-9. doi: 10.1016/j.cct.2013.09.004. Epub 2013 Sep 19.
3
Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis.囊性纤维化患者气道清理的呼气正压物理治疗
Cochrane Database Syst Rev. 2015 Jun 17(6):CD003147. doi: 10.1002/14651858.CD003147.pub4.
4
[Lung physiotherapy in cystic fibrosis].[囊性纤维化中的肺部物理治疗]
Tidsskr Nor Laegeforen. 1991 Feb 28;111(6):720-2.
5
Quality of life and healthcare utilisation in cystic fibrosis: a multicentre study.囊性纤维化的生活质量和医疗保健利用：一项多中心研究。
Eur Respir J. 2013 Mar;41(3):571-7. doi: 10.1183/09031936.00224911. Epub 2012 Jul 26.
6
Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study.肺动脉增大与囊性纤维化肺部恶化：一项队列研究。
Lancet Respir Med. 2016 Aug;4(8):636-645. doi: 10.1016/S2213-2600(16)30105-9. Epub 2016 Jun 10.
7
Design and powering of cystic fibrosis clinical trials using pulmonary exacerbation as an efficacy endpoint.使用肺部恶化作为疗效终点设计和推动囊性纤维化临床试验。
J Cyst Fibros. 2011 Dec;10(6):453-9. doi: 10.1016/j.jcf.2011.07.003. Epub 2011 Jul 30.
8
Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis.肺脏恶化对囊性纤维化患者长期肺功能下降的影响。
Eur Respir J. 2012 Jul;40(1):61-6. doi: 10.1183/09031936.00159111. Epub 2011 Dec 1.
9
Cystic Fibrosis Frequently Asked Questions. Question 3: How do you define a pulmonary exacerbation in Cystic Fibrosis?囊性纤维化常见问题解答。问题3：如何定义囊性纤维化中的肺部加重？
Paediatr Respir Rev. 2015 Sep;16(4):249-50. doi: 10.1016/j.prrv.2015.01.002.
10
Early Lung Function Decline in Cystic Fibrosis. Can Registry Data Explain Divergent Phenotypes?囊性纤维化患者的早期肺功能下降。登记数据能否解释不同的表型？
Am J Respir Crit Care Med. 2017 Aug 15;196(4):407-409. doi: 10.1164/rccm.201704-0813ED.

引用本文的文献

1
Diminished airway host innate response in people with cystic fibrosis who experience frequent pulmonary exacerbations.囊性纤维化患者频繁发生肺部恶化时，气道固有免疫反应减弱。
Eur Respir J. 2024 Feb 22;63(2). doi: 10.1183/13993003.01228-2023. Print 2024 Feb.

本文引用的文献

1
Antibiotics and outcomes of CF pulmonary exacerbations in children infected with MRSA and Pseudomonas aeruginosa.耐甲氧西林金黄色葡萄球菌和铜绿假单胞菌感染儿童 CF 肺部加重的抗生素治疗与结局。
J Cyst Fibros. 2023 Mar;22(2):313-319. doi: 10.1016/j.jcf.2022.08.001. Epub 2022 Aug 7.
2
Acute Pulmonary Exacerbation Phenotypes in Patients with Cystic Fibrosis.囊性纤维化患者的急性肺部恶化表型。
Ann Am Thorac Soc. 2022 Nov;19(11):1818-1826. doi: 10.1513/AnnalsATS.202111-1266OC.
3
C-reactive protein (CRP) as a biomarker of pulmonary exacerbation presentation and treatment response.
C-反应蛋白（CRP）作为肺部恶化表现和治疗反应的生物标志物。
J Cyst Fibros. 2022 Jul;21(4):588-593. doi: 10.1016/j.jcf.2021.12.003. Epub 2021 Dec 18.
4
A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment.一项囊性纤维化肺部感染加重治疗中抗菌疗程的随机临床试验。
Am J Respir Crit Care Med. 2021 Dec 1;204(11):1295-1305. doi: 10.1164/rccm.202102-0461OC.
5
Association Between Number of Intravenous Antipseudomonal Antibiotics and Clinical Outcomes of Pediatric Cystic Fibrosis Pulmonary Exacerbations.静脉用抗假单胞菌抗生素数量与儿童囊性纤维化肺部加重的临床结局之间的关联。
Clin Infect Dis. 2021 Nov 2;73(9):1589-1596. doi: 10.1093/cid/ciab525.
6
Antimicrobial resistance: Concerns of healthcare providers and people with CF.抗微生物药物耐药性：医疗保健提供者和 CF 患者的关注。
J Cyst Fibros. 2021 May;20(3):407-412. doi: 10.1016/j.jcf.2020.05.009. Epub 2020 Jun 17.
7
The use of antimicrobial susceptibility testing in pediatric cystic fibrosis pulmonary exacerbations.在儿科囊性纤维化肺部感染加重时使用抗菌药物敏感性测试。
J Cyst Fibros. 2019 Nov;18(6):851-856. doi: 10.1016/j.jcf.2019.05.012. Epub 2019 May 28.
8
Standardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbations.标准化治疗肺部加重（STOP）研究：囊性纤维化肺部加重静脉内抗生素治疗开始时的观察。
J Cyst Fibros. 2017 Sep;16(5):592-599. doi: 10.1016/j.jcf.2017.04.005. Epub 2017 Apr 29.
9
Standardized Treatment of Pulmonary Exacerbations (STOP) study: Physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary Exacerbations.标准化治疗肺部加重（STOP）研究：患有肺部加重的囊性纤维化患者的医生治疗实践和结果。
J Cyst Fibros. 2017 Sep;16(5):600-606. doi: 10.1016/j.jcf.2017.04.003. Epub 2017 Apr 29.
10
The cumulative effects of intravenous antibiotic treatments on hearing in patients with cystic fibrosis.静脉注射抗生素治疗对囊性纤维化患者听力的累积影响。
J Cyst Fibros. 2017 May;16(3):401-409. doi: 10.1016/j.jcf.2017.01.006. Epub 2017 Feb 24.